Investors Alerted to Class Action Lawsuit Against Veradigm Inc. by National Law Firm

NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- National stockholder rights law firm Bragar Eagel & Squire, P.C. has issued a reminder to investors that a class action lawsuit has been initiated against Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.), symbol MDRX, alleging violations of federal securities laws. Investors who purchased or otherwise acquired shares of Veradigm are encouraged to contact the firm for more details regarding the lawsuit.

Background of Veradigm Inc.

Headquartered in Chicago, Illinois, Veradigm Inc. is a prominent provider of information technology solutions and services tailored to meet the needs of healthcare organizations across the United States, Canada, and internationally. The company's aim is to improve clinical, financial, and operational results in the healthcare sector through innovative technology.

Details of the Lawsuit

The lawsuit filed in the United States District Court alleges that Veradigm Inc. disseminated misleading information to investors, violating securities laws. The legal action seeks to recover damages on behalf of investors who suffered losses due to the alleged misrepresentations by the company.

Participation in the Class Action

Investors who have acquired shares of Veradigm's stock MDRX during the specified period and incurred losses are eligible to participate in the class action lawsuit. Bragar Eagel & Squire, P.C. urges affected investors to reach out to the firm to learn more about their rights and options in this matter.

How to Contact the Law Firm

Investors are encouraged to contact Bragar Eagel & Squire, P.C. for additional information about the lawsuit and to discuss their potential claims. The law firm advises prompt action to ensure the preservation of rights within the given legal timelines.

lawsuit, reminder, investors